Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer
Clinical trial NCT03586297 · COMPLETED
Trial details
- NCT number
- NCT03586297
- Sponsor
- Hackensack Meridian Health
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-08-27
- Primary completion
- 2025-09-15
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.